GH Research Ownership | Who Owns GH Research?
GH Research Ownership Summary
GH Research is owned by 77.41% institutional investors, 24.20% insiders. Bvf inc/il is the largest institutional shareholder, holding 13.95% of GHRS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.30% of its assets in GH Research shares.
GHRS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GH Research | 77.41% | 24.20% | -1.61% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
| Idea | Psychedelic Stocks List | 56.05% | 8.83% | 35.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 8.65M | 13.95% | $121.62M |
| Ra capital management | 7.68M | 12.38% | $107.93M |
| Rtw investments, lp | 5.93M | 9.57% | $83.43M |
| Fmr | 5.14M | 8.28% | $72.21M |
| Avoro capital advisors | 1.80M | 2.90% | $25.31M |
| Millennium management | 937.90K | 1.51% | $13.19M |
| Jefferies financial group | 712.30K | 1.15% | $10.01M |
| Stempoint capital lp | 545.27K | 0.88% | $7.80M |
| Blackrock funding, inc. /de | 455.62K | 0.73% | $6.41M |
| Ubs group | 412.42K | 0.66% | $5.80M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bvf inc/il | 8.65M | 3.87% | $121.62M |
| Stempoint capital lp | 545.27K | 1.56% | $7.80M |
| Ra capital management | 7.68M | 1.14% | $107.93M |
| Foresite capital management vi | 315.49K | 0.96% | $4.44M |
| Lion point capital, lp | 10.20K | 0.86% | $143.41K |
| Rtw investments, lp | 5.93M | 0.83% | $83.43M |
| Highvista strategies | 213.21K | 0.83% | $3.00M |
| Avoro capital advisors | 1.80M | 0.25% | $25.31M |
| Advisorshares investments | 67.03K | 0.17% | $942.50K |
| Centerbook partners lp | 216.57K | 0.16% | $3.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 937.90K | 0.01% | 641.97K |
| Stempoint capital lp | 545.27K | 1.56% | 444.45K |
| Foresite capital management vi | 315.49K | 0.96% | 315.49K |
| Boothbay fund management | 282.89K | 0.05% | 170.71K |
| Point72 asset management | 76.96K | 0.00% | 76.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | - | - | -10.76M |
| Toronto dominion bank | - | - | -1.40M |
| Cormorant asset management, lp | - | - | -1.30M |
| Deep track capital, lp | - | - | -1.25M |
| Troluce capital advisors | - | - | -990.47K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Foresite capital management vi | 315.49K | 0.96% | 315.49K | $4.44M |
| Point72 asset management | 76.96K | 0.00% | 76.96K | $1.10M |
| Tang capital management | 24.03K | 0.01% | 24.03K | $343.63K |
| Cubist systematic strategies | 22.73K | 0.00% | 22.73K | $325.07K |
| Man group | 22.06K | 0.00% | 22.06K | $315.46K |
Sold Out
| Holder | Change |
|---|---|
| Group one trading | -100.00 |
| Qube research | -109.00 |
| Daiwa securities group | -207.00 |
| Arkos global advisors | -1.18K |
| Tortoise investment management | -1.78K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 68 | 23.64% | 51,506,265 | 8.32% | 77 | 1.32% | 37 | 19.35% | 17 | 21.43% |
| Mar 31, 2026 | 17 | -70.69% | 12,218,777 | -73.76% | 19 | 0.35% | 9 | -71.88% | 4 | -73.33% |
| Dec 31, 2025 | 31 | -36.73% | 3,352,075 | -92.47% | 5 | 0.10% | 18 | -47.06% | 8 | -11.11% |
| Sep 30, 2025 | 24 | -33.33% | 15,997,108 | -63.03% | 25 | 0.46% | 19 | -9.52% | 3 | -66.67% |
| Jun 30, 2025 | 37 | 2.78% | 43,553,080 | 3.97% | 75 | 1.44% | 22 | - | 9 | 12.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 2.95M | 4.30% | 55.20K |
| Fidelity Growth Compy Commingled Pl O | 1.42M | 2.74% | - |
| Fidelity Growth Company Fund | 1.86M | 2.71% | 42.11K |
| RTW Biotech Opportunities Ord | 803.70K | 1.30% | 803.70K |
| Fidelity Growth Company K6 | 605.54K | 0.88% | 14.79K |
| Fidelity Series Growth Company | 467.90K | 0.68% | 10.60K |
| iShares Biotechnology ETF | 356.39K | 0.52% | -1.09K |
| Horizons Psychedelic Stock ETF | 89.31K | 0.17% | -14.21K |
| Fidelity Select Biotechnology | 92.50K | 0.13% | - |
| AdvisorShares Psychedelics ETF | 83.47K | 0.12% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | - |
GHRS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools